Largest companies by net assets
net assets
| Company | Net assets | Sector | Industry | Country | Exchange |
|---|---|---|---|---|---|
| 101 | $239.17M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 102 | $233.41M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 103 | $220.58M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 104 | $220.19M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 105 | $219.25M | Healthcare | Pharmaceuticals | United States | NYSE |
| 106 | $218.61M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 107 | $217.65M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 108 | $217.13M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 109 | $216.87M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 110 | $214.58M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 111 | $211.14M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 112 | $209.89M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 113 | $204.62M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 114 | $204.16M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 115 | $201.86M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 116 | $195.11M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 117 | $190.74M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 118 | $186.06M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 119 | $177.01M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 120 | $172.96M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 121 | $172.11M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 122 | $168.80M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 123 | $165.29M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 124 | $164.14M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 125 | $163.25M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 126 | $148.27M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 127 | $146.93M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 128 | $143.66M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 129 | $143.65M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 130 | $139.32M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 131 | $138.54M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 132 | $137.66M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 133 | $136.19M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 134 | $133.73M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 135 | $130.85M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 136 | $128.46M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 137 | $128.06M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 138 | $127.58M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 139 | $127.38M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 140 | $120.14M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 141 | $119.53M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 142 | $113.59M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 143 | $106.45M | Healthcare | Pharmaceuticals | United States | NYSE |
| 144 | $103.09M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 145 | $102.98M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 146 | $101.93M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 147 | $101.07M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 148 | $100.69M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 149 | $94.50M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 150 | $86.67M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 151 | $85.71M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 152 | $83.73M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 153 | $83.30M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 154 | $80.37M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 155 | $78.63M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 156 | $75.92M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 157 | $74.80M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 158 | $72.26M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 159 | $71.50M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 160 | $68.37M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 161 | $67.37M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 162 | $66.61M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 163 | $65.98M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 164 | $64.10M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 165 | $63.61M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 166 | $56.02M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 167 | $55.20M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 168 | $53.27M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 169 | $49.84M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 170 | $49.40M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 171 | $48.43M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 172 | $48.21M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 173 | $46.59M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 174 | $44.20M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 175 | $43.28M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 176 | $42.87M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 177 | $41.62M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 178 | $40.38M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 179 | $39.23M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 180 | $38.47M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 181 | $38.17M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 182 | $37.89M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 183 | $37.27M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 184 | $36.18M | Healthcare | Pharmaceuticals | United States | NYSE |
| 185 | $35.27M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 186 | $35.09M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 187 | $34.53M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 188 | $33.59M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 189 | $33.02M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 190 | $33.01M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 191 | $32.11M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 192 | $29.87M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 193 | $27.54M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 194 | $27.13M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 195 | $26.86M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 196 | $26.83M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 197 | $25.02M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 198 | $24.60M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 199 | $24.52M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 200 | $24.48M | Healthcare | Pharmaceuticals | United States | Nasdaq |
U.S.-exchange common stocks; ADRs and funds excluded. 333 companies. Reported USD values. TTM means trailing twelve months; companies without a comparable value are excluded.